These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 989476)

  • 1. Bioavailability of tolamolol.
    Faulkner JK; Stopher DA; Walden R; Singleton W; Taylor SH
    Eur J Clin Pharmacol; 1976 Feb; 9(4):315-7. PubMed ID: 989476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacological studies with tolamolol in man.
    Faulkner JK; Stopher DA; Walden R
    Br J Clin Pharmacol; 1975 Oct; 2(5):423-8. PubMed ID: 786354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tolamolol and propranolol on exercise heart rate and angina.
    Aronow WS; Spivacek N; Laverty W; Warren M
    Clin Pharmacol Ther; 1975 Apr; 17(4):379-84. PubMed ID: 1173059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tolamolol in the treatment of hypertension.
    Routledge PA; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1977 Nov; 12(3):171-4. PubMed ID: 579342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.
    Warrington SJ; Turner P; Kilborn JR; Bianchetti G; Morselli PL
    Br J Clin Pharmacol; 1980 Nov; 10(5):449-52. PubMed ID: 6108127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate bioavailability from two extended-release formulations.
    González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.
    Regårdh CG; Johnsson G; Jordö L; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):45-58. PubMed ID: 1079687
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic blockade of the lung. Dose-dependent cardioselectivity of tolamolol in asthma.
    Fleming GM; Chester EH; Schwartz HJ; Jones PK
    Chest; 1978 Jun; 73(6):807-12. PubMed ID: 350512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise.
    Wilkins MR; Woods KL; Jack DB; Kendall MJ; Laugher SJ
    Eur J Clin Pharmacol; 1985; 28(2):113-7. PubMed ID: 3987793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of indomethacin tablets in men volunteers.
    Groth PE; Dunn JM
    Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.